Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast ...

The FDA updated prescribing information for Elevidys with new safety warnings and limiting its use to DMD patients who can ...

The inventor of base and prime editing shares insights on medicine's efforts to make serious genetic diseases treatable or ...

Akadeum Life Sciences, the leader in buoyant cell separation, announced today that it has submitted a Type II Drug Master ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...

At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...

Cincinnati Children's dedicated a new research center in Sharonville to finding treatments for patients with cancer, blood ...

Sharonville, Ohio, celebrates the opening of the new Cincinnati Children's Applied Gene and Cell Therapy Center.